About Merieux Equity Partners
Merieux Equity Partners is a company based in Lyon (France). It operates as a B2B. Merieux Equity Partners has completed 7 acquisitions, including Curea medical, Doc Generici and InnoSyn.
- Headquarter Lyon, France
-
Sectors
Financial Services
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
Curea medical
& 6 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Merieux Equity Partners
Unlock access to complete
Funding Insights of Merieux Equity Partners
Detailed funding history for Merieux Equity Partners
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Merieux Equity Partners
Merieux Equity Partners has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Curea medical, Doc Generici and InnoSyn.
Investment portfolio details for Merieux Equity Partners
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provides research and development of chemical processes
|
Locked | Locked | 2017 | Locked | |
|
Wound dressing solutions are developed using supercore technology.
|
Locked | Locked | 2010 | Locked | |
|
Food supplements are distributed by NUTRAGROUP in the French market.
|
Locked | Locked | 2008 | Locked |
Complete acquisition details for Merieux Equity Partners
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Merieux Equity Partners
Detailed financials for Merieux Equity Partners
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Merieux Equity Partners Comparisons
Peer comparison for Merieux Equity Partners
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Merieux Equity Partners
Detailed competitors of Merieux Equity Partners
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Merieux Equity Partners
Complete news archive for Merieux Equity Partners
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Merieux Equity Partners
Merieux Equity Partners is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
Merieux Equity Partners is headquartered in Lyon, France, where operations as a private equity firm are conducted. Focus is placed on healthcare and nutrition sectors, with investments directed toward biotech, diagnostics, and related sub-sectors. High-potential companies are supported through capital provision and operational guidance to facilitate development and expansion across Europe and beyond.
Merieux Equity Partners has made 7 acquisitions, including Curea medical, Doc Generici, and InnoSyn.